Table 2.
Summary of Study Designs from the 24 PDAC Papers.
| Analytical Techniques | ||||
|---|---|---|---|---|
| NMR | MS | Both | ||
| 6 | 17 | 1 | ||
| NMR Data | ||||
| 1D | 1D & 2D | |||
| 5 | 2 | |||
| MS Data a | ||||
| MS | MS/MS | MS and MS/MS | ||
| 4 | 8 | 5 | ||
| Fold Change | ||||
| Qualitative | Quantitative | |||
| 17 | 7 | |||
| Data Deposited b | ||||
| Yes | No | |||
| 5 | 19 | |||
| Control Samples | ||||
|
Healthy/normal
control |
Chronic
pancreatitis/benign pancreatic disease |
Adjacent, non-tumor
tissue |
Benign hepatobiliary disease | |
| 16 | 5 | 2 | 1 | |
| Sample Sources | ||||
| Urine | Serum | Plasma | Tissue | Exosomes |
| 3 | 13 | 4 | 3 | 1 |
a Fragments used to identify metabolites; b Includes data that is available upon request to authors.